India's Dr Reddy's says U.S. regulator lifts ban on Mexico plant (Photo : Flickr)
Dr Reddy's Laboratories, India's No. 2 drugmaker by sales, said the U.S. drug regulator has lifted a ban on its manufacturing unit in Mexico and that it can start shipping products from the facility to the United States.
The U.S. Food and Drug Administration had issued a warning letter to the company's manufacturing unit at Cuernavaca in June last year saying it had violated manufacturing standards, and stopped shipments to the U.S.
Like Us on Facebook
Dr Reddy's said in a statement late on Friday it worked with the regulator to resolve the issues it had raised, after which it received a "clearance" from the USFDA on July 26.
The unit in Mexico makes bulk drugs.